Analysis of leukemia related oncogene and mRNA using double staining fo nucleic acid and protein
核酸和蛋白质双染色分析白血病相关癌基因和 mRNA
基本信息
- 批准号:62570436
- 负责人:
- 金额:$ 1.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1988
- 资助国家:日本
- 起止时间:1988 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
With flow-cyto metry, it would be able to elucidate the cell cycle by measuring and analysing the DNA volume. We studied the flow-cyto metry as well as chromosome analysis and immuno cyto chemical staning.(1) Leukemia cell have two lineages, i.e., one with G_1 and SG_2M and other only with SG_2M. conservative methodology failed to visualize the latter lineage. The fact would express the poly clonal character of the cells. Similarly, neuroblastoma cell revealed the more than two cell lineages. There findings showed the traverse distrubance on S-phase, expressing the presense of silent S which is noted regarding to the clonal evolution and oncogene amplification.(2) Flow-cyto metry is very useful for the detection of chromosmal aberration of neuriblastoma. Cases with hyperdiploidity and near diploidity were considered as good prognosis, but cases with near diploidity, hypotetraploidity were as poor prognosis. N-myc amplification was found only among the latter cases.(3) In addition, immunohistochemical staining utilizing neuro specific enolase was done on neuroblastoma cells. As the staining was remarkeably specific, it is now on trial whether the sataing of the neuroblastoma cells can be applied with FCM and cell biology.
用流式细胞仪,可以通过测量和分析DNA体积来阐明细胞周期。我们对流式细胞术、染色体分析和免疫细胞化学染色进行了研究。(1)白血病细胞有两个谱系,即,一个具有G_1和SG_2M,另一个仅具有SG_2M。保守的方法论未能将后一种谱系形象化。这一事实将表达细胞的多克隆特性。同样,神经母细胞瘤细胞也显示出两种以上的细胞谱系。结果表明,S期的横向紊乱,表现为沉默S的存在,这与克隆进化和癌基因扩增有关。(2)流式细胞术是检测神经母细胞瘤染色体畸变的有效方法。超二倍体和近二倍体预后好,近二倍体和低四倍体预后差。N-myc扩增仅见于后者。(3)此外,利用神经特异性烯醇化酶对神经母细胞瘤细胞进行免疫组织化学染色。由于该染色方法特异性强,因此,FCM和细胞生物学方法能否应用于神经母细胞瘤细胞的定位尚待进一步研究。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
H.Hayashi,;H.Muchi,et al: Cancer. 63. 126-132 (1989)
H.Hayashi,;H.Muchi,等:癌症。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hiromu,Muchi; Hiroko,Ijima; Hideo,Shimoizumi,: "Detection of Neuroblastoma cells in the bone marrow with immunohistochemical staining of neurone specific enolase" Pediatric Hematology and Oncology. 6. 63-66 (1989)
弘、穆奇;
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Hayashi;H.Muchi;et al.: Cancer. 63. 126-132 (1989)
H.Hayashi;H.Muchi;等:癌症。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAKINO Shun-ichi其他文献
MAKINO Shun-ichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Innovation of the novel therapeutic strategies against p53 mutated acute myeloid leukemia.
p53突变急性髓系白血病新治疗策略的创新。
- 批准号:
23K07824 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Operating Grants
Targeting Menin in Acute Leukemia with Upregulated HOX Genes
通过上调 HOX 基因靶向急性白血病中的 Menin
- 批准号:
10655162 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Targeting PLK1 in RAS mutant chronic myelomonocytic leukemia
RAS 突变型慢性粒单核细胞白血病中的靶向 PLK1
- 批准号:
10656778 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Fast-kinetics approaches to define direct gene-regulatory functions of MYB in leukemia
快速动力学方法定义 MYB 在白血病中的直接基因调控功能
- 批准号:
10644259 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
TET2-mediated epitranscriptomic regulation in leukemia microenvironment
TET2介导的白血病微环境中的表观转录组调控
- 批准号:
10801348 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Combinatorial targeting for the treatment of B-cell acute lymphoblastic leukemia
治疗 B 细胞急性淋巴细胞白血病的组合靶向
- 批准号:
10973162 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Development of Synergistic Drug Combinations to Overcome Venetoclax Resistance in Acute Myeloid Leukemia
开发协同药物组合来克服急性髓系白血病的维奈托克耐药性
- 批准号:
23K07816 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Setting a new research agenda in North American pediatric acute lymphoblastic leukemia
制定北美儿童急性淋巴细胞白血病的新研究议程
- 批准号:
486909 - 财政年份:2023
- 资助金额:
$ 1.41万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




